ImportRefusal LogoImportRefusal

APIMAB Laboratoires

⚠️ Moderate Risk

FEI: 3007508464 • Clermont L'Herault, Herault • FRANCE

FEI

FEI Number

3007508464

📍

Location

Clermont L'Herault, Herault

🇫🇷

Country

FRANCE
🏢

Address

Avenue Du Lac, , Clermont L'Herault, Herault, France

Moderate Risk

FDA Import Risk Assessment

34.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

18
Total Refusals
11
Unique Violations
3/5/2019
Latest Refusal
1/13/2009
Earliest Refusal

Score Breakdown

Violation Severity
47.3×40%
Refusal Volume
47.4×30%
Recency
0.0×20%
Frequency
17.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1189×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4738×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4826×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

4884×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

2182×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

23002×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

3351×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

Refusal History

DateProductViolationsDivision
3/5/2019
66YDY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
3280FRNMFGREG
335LACKS N/C
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/8/2012
54FEY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
473LABELING
482NUTRIT LBL
New Orleans District Office (NOL-DO)
2/8/2012
54FEQ99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
482NUTRIT LBL
488HEALTH C
New Orleans District Office (NOL-DO)
2/8/2012
54FEK99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
473LABELING
488HEALTH C
New Orleans District Office (NOL-DO)
2/8/2012
54FEQ99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
473LABELING
482NUTRIT LBL
488HEALTH C
New Orleans District Office (NOL-DO)
2/8/2012
54FEY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
473LABELING
482NUTRIT LBL
488HEALTH C
New Orleans District Office (NOL-DO)
2/8/2012
54FEY99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
473LABELING
482NUTRIT LBL
New Orleans District Office (NOL-DO)
2/8/2012
53GK05LIPSTICK (MAKEUP PREPARATIONS, NOT FOR EYES)
471CSTIC LBLG
473LABELING
New Orleans District Office (NOL-DO)
2/8/2012
54FEQ99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
218LIST INGRE
2300DIETARYLBL
473LABELING
482NUTRIT LBL
New Orleans District Office (NOL-DO)
2/8/2012
54FEZ99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
218LIST INGRE
320LACKS FIRM
473LABELING
New Orleans District Office (NOL-DO)
2/8/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/12/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New Orleans District Office (NOL-DO)
1/12/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New Orleans District Office (NOL-DO)
1/12/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New Orleans District Office (NOL-DO)
1/12/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New Orleans District Office (NOL-DO)
1/12/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New Orleans District Office (NOL-DO)
1/12/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New Orleans District Office (NOL-DO)
1/13/2009
64WBL99IRRIGATION SOLUTION N.E.C.
118NOT LISTED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is APIMAB Laboratoires's FDA import refusal history?

APIMAB Laboratoires (FEI: 3007508464) has 18 FDA import refusal record(s) in our database, spanning from 1/13/2009 to 3/5/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. APIMAB Laboratoires's FEI number is 3007508464.

What types of violations has APIMAB Laboratoires received?

APIMAB Laboratoires has been cited for 11 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about APIMAB Laboratoires come from?

All FDA import refusal data for APIMAB Laboratoires is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.